In comparison to the free drug combination, the nanoconjugate significantly reduced tumor volume, prolonged survival rate, and remarkably suppressed expression levels of NF-κB p65, COX-2, TNF-α, and Ki-67 in mice bearing an Ehrlich Ascites Tumor (EAT). This evidence concerns the gene MKI67 and neoplasm.